2.06
前日終値:
$1.95
開ける:
$1.95
24時間の取引高:
174.71K
Relative Volume:
0.26
時価総額:
$125.44M
収益:
$4.39M
当期純損益:
$-24.42M
株価収益率:
-3.259
EPS:
-0.6321
ネットキャッシュフロー:
$-22.92M
1週間 パフォーマンス:
-3.29%
1か月 パフォーマンス:
+12.57%
6か月 パフォーマンス:
+47.14%
1年 パフォーマンス:
+158.79%
Equillium Inc Stock (EQ) Company Profile
Compare EQ vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EQ
Equillium Inc
|
2.06 | 125.44M | 4.39M | -24.42M | -22.92M | -0.6321 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
|
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-13 | 開始されました | Roth Capital | Buy |
| 2026-02-25 | 開始されました | Stifel | Buy |
| 2025-03-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 再開されました | Stifel | Buy |
| 2021-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-10 | 再開されました | Stifel | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Equillium Inc (EQ) 最新ニュース
Equillium 2025 10-K: Advancing EQ504 AhR Modulator for Autoimmune & Inflammatory Disease Therapies - Minichart
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Equill - GuruFocus
Equillium Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Equillium Inc. (NASDAQ:EQ) Reports In-Line Q4 Earnings, Highlights Pipeline Progress and Runway into 2029 - ChartMill
Equillium (EQ) Secures Financial Path to 2029, Focuses on Key Dr - GuruFocus
Equillium (NASDAQ:EQ) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
EQUILLIUM ($EQ) Releases Q4 2025 Earnings - Quiver Quantitative
Equillium (NASDAQ: EQ) expands autoimmune pipeline and raises $65M in private financings - Stock Titan
Equillium (EQ) shifts to EQ504 focus, raises $85M and funds into 2029 - Stock Titan
Equillium says cash can fund ulcerative colitis drug push into 2029 - Stock Titan
Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Yahoo! Finance Canada
Equillium Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
RA Capital group reports 9.9% stake in EQ (NASDAQ: EQ) via warrants - Stock Titan
Macro Review: What is the target price for Equillium Inc stock2026 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
Equillium (EQ) Expected to Announce Earnings on Thursday - MarketBeat
Equillium, Inc. Hits New 52-Week High of $2.62, Up 249% - Markets Mojo
Equillium to Participate in the 38th Annual Roth Conference - Bitget
Biotech Equillium set for Roth fireside chat, investor talks - Stock Titan
Risk Recap: Can Equillium Inc reach all time highs this year2026 Intraday Action & Expert Approved Momentum Ideas - baoquankhu1.vn
Equillium, Inc. Hits New 52-Week High of $2.70, Up 228% Yearly - Markets Mojo
Equillium (NASDAQ:EQ) COO Sells $300,780.00 in Stock - MarketBeat
Equillium (EQ) SVP Zedelmayer sells $300k in shares By Investing.com - Investing.com Canada
Equillium (EQ) SVP Zedelmayer sells $300k in shares - Investing.com
Equillium (EQ) COO exercises options and sells 120,312 shares under plan - Stock Titan
This analyst loves Equillium - Cantech Letter
Cantor Fitzgerald L. P. Invests $608,000 in Equillium, Inc. $EQ - MarketBeat
Equillium Strengthens Financial Position with New Investments - StocksToTrade
Equillium: $35 Million Raised For Biotech Therapy Development - Pulse 2.0
Equillium (NASDAQ:EQ) Coverage Initiated at Roth Mkm - Defense World
Analysts Are Bullish on Top Healthcare Stocks: Equillium (EQ), Qiagen (QGEN) - The Globe and Mail
Equillium (NASDAQ:EQ) Raised to "Hold" at Wall Street Zen - MarketBeat
Equillium secures $35M financing from RA Capital Management By Investing.com - Investing.com South Africa
Equillium secures $35M financing from RA Capital Management - Investing.com Australia
Proposed resale of 120,312 EQ shares reported (EQ) - Stock Titan
EQ SEC FilingsEquillium 10-K, 10-Q, 8-K Forms - Stock Titan
Equillium (EQ) Secures $35 Million Through RA Capital Management Investment - GuruFocus
Equillium (EQ) Receives Buy Rating from Roth Capital | EQ Stock News - GuruFocus
Roth Mkm Initiates Coverage on Equillium (NASDAQ:EQ) - MarketBeat
Equillium, Inc. (NASDAQ:EQ) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Equillium Raises Capital Through Private Equity Securities Sale - TipRanks
Equillium Enters Into $35 Million Securities Purchase Agreement With RA Capital Management - marketscreener.com
Equillium Announces $35 Million Financing with RA Capital Management - Bitget
Equillium Raises $35 Million in Private Placement With RA Capital - TradingView
Equillium (EQ) to raise $35.0 million via shares and pre-funded warrant - Stock Titan
Equillium Secures $35 Million Funding Commitment from RA Capital to Advance EQ504 Clinical Development - Quiver Quantitative
Roth/MKM initiates Equillium stock with buy on ulcerative colitis drug - Investing.com Australia
Form 144 Equillium For: 13 March By Investing.com - Investing.com Canada
Equillium SVP Zedelmayer sells $328k in shares By Investing.com - Investing.com South Africa
Equillium SVP Zedelmayer sells $328k in shares - Investing.com
Equillium (NASDAQ:EQ) COO Sells $362,438.00 in Stock - MarketBeat
Equillium (EQ) COO exercises options, sells 185,937 pre-planned shares - Stock Titan
Equillium Inc (EQ) 財務データ
収益
当期純利益
現金流量
EPS
Equillium Inc (EQ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zedelmayer Christine | Sr. Vice President and COO |
Mar 13 '26 |
Sale |
2.50 |
120,312 |
300,816 |
62,586 |
大文字化:
|
ボリューム (24 時間):